Effectiveness of gabapentin in reducing opioid requirements after radiation in head and neck cancer in a single institution.

Background: Gabapentin has been shown to reduce opioid use in head and neck cancer patients. Here, we examine the efficacy of prophylactic gabapentin at reducing opioid use in these patients at our institution.

Methods: A retrospective study of patients receiving radiation was performed, using patients from our previous study as controls.